Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Timothy Garvey

Showing results (71-80 of 265) with videos related to

Pageof 27
Sort By:
Metabolic Syndrome and Related Disorders|June 25, 2014
Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistanceIrina Shalaurova, Margery A Connelly, W Timothy Garvey, et al.
Obesity Science & Practice|May 6, 2024
Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP-1, GIP receptor agonists, and dual agonistsW Timothy Garvey, Cathy D Mahle, Trevor Bell, et al.
Journal of Cardiovascular Pharmacology|November 18, 2006
Administration of pioglitazone in low-density lipoprotein receptor-deficient mice inhibits lesion progression and matrix metalloproteinase expression in advanced atherosclerotic plaquesLin He, Bryan A Game, Alena Nareika, et al.
Journal of the American College of Cardiology|February 8, 2020
Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art ReviewJeffrey I Mechanick, Michael E Farkouh, Jonathan D Newman, et al.
Obesity (Silver Spring, Md.)|September 11, 2025
Adaptive Thermogenesis After Hypocaloric Low-Carbohydrate Versus Low-Fat Diets in African American Women: A Secondary AnalysisSilvia Y Lopez Torres, Barbara A Gower, W Timothy Garvey, et al.
Journal of the American College of Cardiology|February 8, 2020
Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art ReviewJeffrey I Mechanick, Michael E Farkouh, Jonathan D Newman, et al.
Postgraduate Medicine|July 9, 2016
Impact of lorcaserin on glycemic control in overweight and obese patients with type 2 diabetes: analysis of week 52 responders and nonrespondersXavier Pi-Sunyer, William Shanahan, Randi Fain, et al.
Journal of Managed Care & Specialty Pharmacy|July 20, 2022
Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort studyStephanie Watkins, Joshua C Toliver, Nina Kim, et al.
Metabolites|December 23, 2022
Epigenetic Age Acceleration in Mothers and Offspring 4-10 Years after a Pregnancy Complicated by Gestational Diabetes and ObesityNita Kanney, Amit Patki, Paula Chandler-Laney, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 15, 2019
DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENTJeffrey I Mechanick, Alan J Garber, George Grunberger, et al.
Pageof 27

Showing results (71-80 of 265) with videos related to

Sort By:
Pageof 27
Metabolic Syndrome and Related Disorders|June 25, 2014
Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistanceIrina Shalaurova, Margery A Connelly, W Timothy Garvey, et al.
Obesity Science & Practice|May 6, 2024
Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP-1, GIP receptor agonists, and dual agonistsW Timothy Garvey, Cathy D Mahle, Trevor Bell, et al.
Journal of Cardiovascular Pharmacology|November 18, 2006
Administration of pioglitazone in low-density lipoprotein receptor-deficient mice inhibits lesion progression and matrix metalloproteinase expression in advanced atherosclerotic plaquesLin He, Bryan A Game, Alena Nareika, et al.
Journal of the American College of Cardiology|February 8, 2020
Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art ReviewJeffrey I Mechanick, Michael E Farkouh, Jonathan D Newman, et al.
Obesity (Silver Spring, Md.)|September 11, 2025
Adaptive Thermogenesis After Hypocaloric Low-Carbohydrate Versus Low-Fat Diets in African American Women: A Secondary AnalysisSilvia Y Lopez Torres, Barbara A Gower, W Timothy Garvey, et al.
Journal of the American College of Cardiology|February 8, 2020
Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art ReviewJeffrey I Mechanick, Michael E Farkouh, Jonathan D Newman, et al.
Postgraduate Medicine|July 9, 2016
Impact of lorcaserin on glycemic control in overweight and obese patients with type 2 diabetes: analysis of week 52 responders and nonrespondersXavier Pi-Sunyer, William Shanahan, Randi Fain, et al.
Journal of Managed Care & Specialty Pharmacy|July 20, 2022
Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort studyStephanie Watkins, Joshua C Toliver, Nina Kim, et al.
Metabolites|December 23, 2022
Epigenetic Age Acceleration in Mothers and Offspring 4-10 Years after a Pregnancy Complicated by Gestational Diabetes and ObesityNita Kanney, Amit Patki, Paula Chandler-Laney, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 15, 2019
DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENTJeffrey I Mechanick, Alan J Garber, George Grunberger, et al.
Pageof 27